Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases.
Aliada Therapeutics has raised $32.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.
Aliada Therapeutics is headquartered in Boston, United States.
Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases.
Aliada Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aliada Therapeutics — Funding & Investors." VCBacked, December 30, 2022, https://www.vcbacked.co/company/aliada-therapeutics. Accessed August 13, 2026.
VCBacked. (2022). Aliada Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/aliada-therapeutics
{{cite web |title=Aliada Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aliada-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated